PL3490988T3 - Nowy związek i sposób - Google Patents

Nowy związek i sposób

Info

Publication number
PL3490988T3
PL3490988T3 PL17748880T PL17748880T PL3490988T3 PL 3490988 T3 PL3490988 T3 PL 3490988T3 PL 17748880 T PL17748880 T PL 17748880T PL 17748880 T PL17748880 T PL 17748880T PL 3490988 T3 PL3490988 T3 PL 3490988T3
Authority
PL
Poland
Prior art keywords
new compound
compound
new
Prior art date
Application number
PL17748880T
Other languages
English (en)
Inventor
Peter Lionel Spargo
Original Assignee
Verona Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Plc filed Critical Verona Pharma Plc
Publication of PL3490988T3 publication Critical patent/PL3490988T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL17748880T 2016-07-28 2017-07-27 Nowy związek i sposób PL3490988T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
EP17748880.6A EP3490988B1 (en) 2016-07-28 2017-07-27 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (1)

Publication Number Publication Date
PL3490988T3 true PL3490988T3 (pl) 2020-02-28

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17748880T PL3490988T3 (pl) 2016-07-28 2017-07-27 Nowy związek i sposób

Country Status (19)

Country Link
US (1) US10710998B2 (pl)
EP (1) EP3490988B1 (pl)
JP (1) JP6985367B2 (pl)
KR (1) KR102396059B1 (pl)
CN (1) CN109641891B (pl)
CY (1) CY1122138T1 (pl)
DK (1) DK3490988T3 (pl)
ES (1) ES2751948T3 (pl)
GB (1) GB201613054D0 (pl)
HR (1) HRP20192109T1 (pl)
HU (1) HUE046509T2 (pl)
LT (1) LT3490988T (pl)
PL (1) PL3490988T3 (pl)
PT (1) PT3490988T (pl)
RS (1) RS59566B1 (pl)
SI (1) SI3490988T1 (pl)
SM (1) SMT201900582T1 (pl)
TW (1) TWI739871B (pl)
WO (1) WO2018020249A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3142701T1 (en) 2014-05-12 2018-08-31 Verona Pharma Plc NEW TREATMENT
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
MX2022008805A (es) * 2020-01-17 2022-08-11 Lupin Ltd Metodos, procesos e intermedios para preparar compuestos cromanos.
KR20240004495A (ko) 2021-04-29 2024-01-11 쑤저우 선카디아 바이오파마수티컬즈 컴퍼니 리미티드 이소퀴놀론 화합물과 이의 용도
EP4450500A4 (en) * 2021-12-14 2025-10-15 Xizang Haisco Pharmaceutical Co Ltd TRICYCLIC FUSED HETEROCYCLIC PDE3/4 DUAL INHIBITOR AND ITS USE
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
TW202506117A (zh) 2023-06-26 2025-02-16 英商維羅納製藥Plc公司 顆粒組成物
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
WO2025052119A1 (en) 2023-09-06 2025-03-13 Verona Pharma Plc Ensifentrine for use in treating chronic obstructive pulmonary disease (copd)
US20250249008A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025168706A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1237429A (en) 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
CN100415743C (zh) * 1999-03-31 2008-09-03 韦尔纳利斯有限公司 嘧啶并[6,1-a] 异喹啉-4-酮衍生物
AR082601A1 (es) 2010-08-09 2012-12-19 Verona Pharma Plc Formas cristalinas de compuestos de pirimido[6,1-a]isoquinolin-4-ona
US9700558B2 (en) 2013-03-15 2017-07-11 Verona Pharma Plc Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
SI3142701T1 (en) 2014-05-12 2018-08-31 Verona Pharma Plc NEW TREATMENT
HUE055527T2 (hu) 2014-09-15 2021-12-28 Verona Pharma Plc RPL554-t tartalmazó folyékony inhalációs készítmény
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Also Published As

Publication number Publication date
KR20190034231A (ko) 2019-04-01
JP2019527228A (ja) 2019-09-26
GB201613054D0 (en) 2016-09-14
EP3490988A1 (en) 2019-06-05
SI3490988T1 (sl) 2019-11-29
CY1122138T1 (el) 2020-11-25
LT3490988T (lt) 2019-10-10
PT3490988T (pt) 2019-10-28
SMT201900582T1 (it) 2019-11-13
CN109641891B (zh) 2021-05-04
US20190330206A1 (en) 2019-10-31
RS59566B1 (sr) 2019-12-31
US10710998B2 (en) 2020-07-14
EP3490988B1 (en) 2019-08-28
JP6985367B2 (ja) 2021-12-22
CN109641891A (zh) 2019-04-16
KR102396059B1 (ko) 2022-05-10
WO2018020249A1 (en) 2018-02-01
HRP20192109T1 (hr) 2020-02-21
HUE046509T2 (hu) 2020-03-30
TW201806951A (zh) 2018-03-01
TWI739871B (zh) 2021-09-21
ES2751948T3 (es) 2020-04-02
DK3490988T3 (da) 2019-10-28

Similar Documents

Publication Publication Date Title
GB201609546D0 (en) Process
SMT201900582T1 (it) Nuovo composto e procedimento
GB201605121D0 (en) Process
GB201615268D0 (en) Process
GB201609873D0 (en) Process
GB201615270D0 (en) Process
GB201612248D0 (en) New process
GB201600290D0 (en) Process
GB201618121D0 (en) Process
GB201615762D0 (en) Process
GB201602584D0 (en) Process
GB201608779D0 (en) Methods and compounds
GB201617500D0 (en) Process
GB201503776D0 (en) Compound and method
GB201617463D0 (en) Process
GB201602646D0 (en) Process
GB201600456D0 (en) Process
GB201600287D0 (en) Process
GB201620655D0 (en) Methanaol process
GB201620667D0 (en) Process
GB201608776D0 (en) Methods and compounds
GB201610852D0 (en) Process
GB201613014D0 (en) Process
GB201604608D0 (en) Process
GB201620525D0 (en) Process